Sutherland, Jayne S.Spuy, Gian van derGindeh, AwaThuong, Nguyen ThuyNamuganga, AnnRitahOwolabi, OlumuyiwaMayanja-Kizza, HarrietNsereko, MaryThwaites, GuyWinter, JillDockrell, Hazel M.Scriba, Thomas J.Geluk, AnnemiekeCorstjens, PaulStanley, KimRichardson, TracyShaw, Jane A.Smith, BronwynWalzl, Gerhard2022-01-302022-01-302021Sutherland, J. S., van der Spuy, G., Gindeh, A., Thuong, N. T. T., Namuganga, A., Owolabi, O., ... & TrENDx-TB Consortium. (2021). Diagnostic accuracy of the Cepheid 3-gene host response fingerstick blood test in a prospective, multi-site study: interim results. Clinical Infectious Diseases. DOI: 10.1093/cid/ciab83910.1093/cid/ciab839https://nru.uncst.go.ug/xmlui/handle/123456789/1644The development of a fast and accurate, non-sputum-based point-of-care triage test for tuberculosis (TB) would have a major impact on combating the TB burden worldwide. A new fingerstick blood test has been developed by Cepheid (the Xpert-MTB-Host Response (HR)-Prototype), which generates a ‘TB score’ based on mRNA expression of 3 genes. Here we describe the first prospective findings of the MTB-HR prototype.enTuberculosisDiagnosticsCepheid 3-gene Host-Response prototypeMulti-siteFingerstick bloodTriage testArticle